Publication:
Clinical Profile of Neonatal RSV Bronchiolitis - A Descriptive Study

creativeworkseries.issnISSN 1990-7974 eISSN 1990-7982
dc.contributor.authorRahul, Aswathy
dc.contributor.authorVenugopal, Aishwarya
dc.contributor.authorRaj, Raunak
dc.contributor.authorPadmanabhan, Athul
dc.contributor.authorNema, Meghna
dc.contributor.authorSujatha, Radhika
dc.date.accessioned2025-10-12T09:38:48Z
dc.date.available2025-10-12T09:38:48Z
dc.date.issued2025
dc.descriptionAswathy Rahul Assistant Professor in Neonatology, Department of Neonatology, Government Medical College, Thiruvananthapuram, Kerala, India Aishwarya Venugopal Senior Resident in Neonatology, Department of Neonatology, Government Medical College, Thiruvananthapuram, Kerala, India Raunak Raj Consultant Neonatologist, Rani Hospital, Ranchi, India Athul Padmanabhan Senior Resident in Neonatology, Department of Neonatology, Government Medical College, Thiruvananthapuram, Kerala, India Meghna Nema Senior Resident in Neonatology, Department of Neonatology, Government Medical College, Thiruvananthapuram, Kerala, India. Radhika Sujatha Professor, Department of Neonatology, Government Medical College, Thiruvananthapuram, Kerala, India
dc.description.abstractAbstract: Introduction: Newborns with viral bronchiolitis may have a turbulent clinical course and Respiratory syncytial virus (RSV) is the most common viral agent causing bronchiolitis in childhood. Methods: This ambispective study was conducted in the outborn nursery of a tertiary care Government Medical College in neonates who were admitted with a working diagnosis of acute bronchiolitis or respiratory tract infection. A retrospective chart review was done for the cases admitted during the outbreaks of August to November 2022 and a prospective study was done from September to December 2023. Results: During the study period, a total of 100 neonates (60 cases in 2022 and 40 cases in 2023) were admitted with respiratory tract infection or bronchiolitis. 75% of the babies had moderate to severe bronchiolitis. Thirteen babies with severe bronchiolitis required invasive ventilation. The most common virus detected was RSV followed by Rhino virus. Among the neonates with RSV infection, 65.71% were term babies. There was no mortality. The most common clinical presentation was cough (N =89) (89%) and the threatening symptom was apnea with cardiorespiratory arrest. Remedesivir, an antiviral agent, was given to two babies with severe RSV bronchiolitis on compassionate ground. Conclusions: Apnea and cardiorespiratory arrest should be anticipated in neonatal bronchiolitis. Remdesivir is an antiviral agent which can be life saving in severe RSV bronchiolitis.
dc.identifierhttps://doi.org/10.60086/jnps1293
dc.identifier.urihttps://hdl.handle.net/20.500.14572/2600
dc.language.isoen_US
dc.publisherPerinatal Society of Nepal (PESON)
dc.subjectAntiviral agents
dc.subjectNeonate
dc.subjectRemdesivir
dc.subjectRespiratory infections
dc.titleClinical Profile of Neonatal RSV Bronchiolitis - A Descriptive Study
dc.typeArticle
dspace.entity.typePublication
local.article.typeOriginal Article
oaire.citation.endPage5
oaire.citation.startPage1
relation.isJournalIssueOfPublication3e271f9b-b888-4f66-9ae4-b5b56d015dd6
relation.isJournalIssueOfPublication.latestForDiscovery3e271f9b-b888-4f66-9ae4-b5b56d015dd6
relation.isJournalOfPublication6f9be05c-05a9-4a3e-a5b5-a19a15ab042c

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
1-5.pdf
Size:
212.49 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.86 KB
Format:
Item-specific license agreed to upon submission
Description:

Collections